Evaluating a Turkish tool for assessing eating difficulties in Sjögren's Syndrome patients
Reliability, Validity, and Responsiveness of the Turkish Version of Eating Assessment Tool-10 for Patients With Primer Sjögren's Syndrome
This study is testing a Turkish tool to see how well it helps understand eating difficulties in people with Sjögren's Syndrome.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Kahramanmaras Sutcu Imam University Academic / other |
| Locations | 1 site (Ankara) |
| Trial ID | NCT06401811 on ClinicalTrials.gov |
What this trial studies
This study evaluates the reliability, validity, and responsiveness of the Turkish version of the Eating Assessment Tool-10 specifically for patients diagnosed with primary Sjögren's Syndrome. Researchers will assess patients' swallowing difficulties and repeat evaluations after one week to ensure consistency. Additionally, a follow-up assessment will occur after three months to measure sensitivity and responsiveness of the tool. The study aims to improve the understanding of eating disorders in this patient population.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with primary Sjögren's Syndrome.
Not a fit: Patients with secondary Sjögren's Syndrome or other uncontrolled significant health conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a validated tool for better assessment and management of swallowing disorders in patients with primary Sjögren's Syndrome.
How similar studies have performed: While similar assessments have been conducted, this specific evaluation of the Turkish Eating Assessment Tool-10 in Sjögren's Syndrome is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with Primary Sjögren's Syndrome * 18 years or older Exclusion Criteria: * Patients with Secondary Sjögren's Syndrome, * Patients who are diagnosed with other uncontrolled/clinically important diseases (chronic obstructive pulmonary disease, congestive heart failure, endocrine system diseases, neurological, psychological diseases, etc.), * Individuals who do not agree to participate in the study and do not give written consent will be excluded from the study.
Where this trial is running
Ankara
- Hacettepe University — Ankara, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Nazli Elif Nacar, MSc
- Email: nelifnacar@ksu.edu.tr
- Phone: +903443004085
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.